Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All ASA-I and ASA-II, female patients getting operated for laparoscopic hysterectomy and consenting to be part of study will be included.
Exclusion criteria
Exclusion criteria: 1. Grade ASA III and above patients 2. Patients not giving consent 3. Patients undergoing laparoscopic hysterectomy as a part of cytoreduction will be excluded from study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare intraoperative hemodynamics, postoperative analgesia, and postoperative side effects (postoperative nausea and vomiting and respiratory distress) between patients receiving intravenous fentanyl and intravenous nalbuphine during laparoscopic hysterectomy.Timepoint: Intraoperative hemodynamics, postoperative analgesia, and postoperative 15 minutes, 30 minutes, 45 minutes, 01 hour, 01 hour 15 minutes, 1 hour 30 minutes, 1 hour 45 minutes and 02 hours and 30 minutes post-oprative. side effects post-oprative nausea vomiting for 30 minutes, 1 hour, 2 hours and 03 hours. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Comparison between Intra-operative Dose Requirement of Inj.Fentanyl and Inj.Nalbuphine to maintain stable Hemodynamics. 2. Comparison between patients on Inj.Fentanyl and Inj.Nalbuphine for Post-operative Rescue Analgesia Required. Timepoint: Intraoperative hemodynamics, postoperative analgesia, and postoperative 15 minutes, 30 minutes, 45 minutes, 01 hour, 01 hour 15 minutes, 1 hour 30 minutes, 1 hour 45 minutes and 02 hours and 30 minutes post-oprative. side effects post-oprative nausea vomiting for 30 minutes, 1 hour, 2 hours and 03 hours. | — |
Countries
India
Contacts
Bhaktivedanta Hospital and Research Institute